<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3474">
  <stage>Registered</stage>
  <submitdate>21/02/2012</submitdate>
  <approvaldate>21/02/2012</approvaldate>
  <nctid>NCT01544777</nctid>
  <trial_identification>
    <studytitle>Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study</studytitle>
    <scientifictitle>Visual Quality Following Aspheric and Monovision Lens Implantation - a Comparative Clinical Study</scientifictitle>
    <utrn />
    <trialacronym>751</trialacronym>
    <secondaryid>DOF-1</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Aphakia</healthcondition>
    <healthcondition>Cataract</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Human Genetics and Inherited Disorders</conditioncode1>
      <conditioncode2>Other human genetics and inherited disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Study IOL
Treatment: devices - Hoya iSert 751
Treatment: devices - Negatively aspheric IOL

Experimental: Both Eyes - Model 751 IOL implanted in both eyes.

Experimental: Single eye - Model 751 IOL in one eye

Active Comparator: Control - Aphakia treatment by negatively aspheric IOL implant, Hoya iSert model 251 or equivalent


Treatment: devices: Study IOL
Aspheric IOL for correction of aphakia

Treatment: devices: Hoya iSert 751
Model 751 in one eye, standard IOL in other eye

Treatment: devices: Negatively aspheric IOL
Negatively aspheric IOL in both eyes

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Uncorrected Visual Acuity (UCVA) (ETDRS)for distance, intermediate and near</outcome>
      <timepoint>Up to 3 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Senile cataract

          -  Patient identified as a candidate for cataract surgery and IOL implantation

          -  Willing to sign informed consent document approved by the Ethical Committee

          -  Willing to complete all required tests and exams per this protocol</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Amblyopia

          -  History or evidence of any ocular disease that may affect visual acuity

          -  Previous ocular surgery, including refraction surgery

          -  Ocular anomalies (e.g. microphthalmos, kerataconous)

          -  Subjects with greater than 1.0 D of corneal astigmatism

          -  Subjects who experience intraoperative complications that could affect postoperative
             IOL centration or tilt</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>42</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/08/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>Sir Charles Gairdner Hospital - Nedlands</hospital>
    <postcode>6009 - Nedlands</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Hoya Surgical Optics, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To evaluate visual acuity and quality of vision in participants undergoing cataract surgery
      with a Hoya model 751 intra-ocular lens and to compare the visual results to the common
      monofocal lens in use.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01544777</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Graham Barrett, MD</name>
      <address>Sir Charles Gairdner Hospital, Nedlans WA</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>